CATALOGO DEI PRODOTTI DELLA RICERCA

BENINI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.742
NA - Nord America 10.621
AS - Asia 6.217
SA - Sud America 718
Continente sconosciuto - Info sul continente non disponibili 309
AF - Africa 87
OC - Oceania 20
Totale 30.714
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.484
IT - Italia 5.025
SG - Singapore 2.705
RU - Federazione Russa 2.479
GB - Regno Unito 2.112
CN - Cina 1.825
FR - Francia 600
BR - Brasile 578
DE - Germania 543
SE - Svezia 504
FI - Finlandia 451
VN - Vietnam 448
HK - Hong Kong 432
IE - Irlanda 369
UA - Ucraina 206
KR - Corea 196
NL - Olanda 156
JP - Giappone 103
IN - India 83
BD - Bangladesh 70
CA - Canada 65
AR - Argentina 58
BE - Belgio 56
TR - Turchia 54
ES - Italia 47
ID - Indonesia 43
PL - Polonia 42
IQ - Iraq 34
IR - Iran 34
SA - Arabia Saudita 34
MX - Messico 31
PK - Pakistan 30
RO - Romania 30
CH - Svizzera 24
EC - Ecuador 19
AU - Australia 18
NG - Nigeria 18
ZA - Sudafrica 16
CL - Cile 15
CO - Colombia 14
LT - Lituania 13
CZ - Repubblica Ceca 12
EG - Egitto 12
IL - Israele 12
AE - Emirati Arabi Uniti 11
UZ - Uzbekistan 11
AT - Austria 9
CR - Costa Rica 9
JO - Giordania 9
MA - Marocco 9
NP - Nepal 9
OM - Oman 9
PE - Perù 9
TN - Tunisia 9
VE - Venezuela 9
BG - Bulgaria 8
KE - Kenya 8
PH - Filippine 8
BO - Bolivia 7
DZ - Algeria 7
EU - Europa 7
MY - Malesia 7
PT - Portogallo 7
PY - Paraguay 7
QA - Qatar 7
TW - Taiwan 7
AZ - Azerbaigian 6
JM - Giamaica 6
KZ - Kazakistan 6
AL - Albania 5
BY - Bielorussia 5
DK - Danimarca 5
AM - Armenia 4
ET - Etiopia 4
HN - Honduras 4
MK - Macedonia 4
PA - Panama 4
RS - Serbia 4
BB - Barbados 3
EE - Estonia 3
GE - Georgia 3
GR - Grecia 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
LU - Lussemburgo 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BZ - Belize 2
DO - Repubblica Dominicana 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
MT - Malta 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
Totale 30.395
Salva come PNG Salva come JPEG
Città #
Southend 1.764
Singapore 1.515
Jacksonville 1.500
Chandler 1.136
Ashburn 814
San Jose 760
Moscow 707
Woodbridge 685
Dallas 563
Ann Arbor 530
Verona 461
Hong Kong 421
Dublin 367
Houston 364
The Dalles 268
Council Bluffs 263
Milan 255
Rome 242
Beijing 219
New York 179
Lawrence 177
Princeton 177
Wilmington 176
Nanjing 151
Los Angeles 141
Ho Chi Minh City 139
Jinan 137
Shenyang 131
Sindelfingen 113
Hanoi 106
Tokyo 99
Munich 89
Buffalo 88
Boardman 86
Helsinki 86
Bologna 82
Tianjin 82
Hebei 79
Naples 66
Santa Clara 62
Ningbo 61
Changsha 59
Brussels 53
São Paulo 51
Zhengzhou 49
Haikou 48
Seattle 48
Nanchang 47
Frankfurt am Main 46
Florence 45
Orem 45
Turin 40
Hangzhou 39
Chicago 37
Columbus 36
Guangzhou 36
Palermo 34
Jiaxing 33
Atlanta 31
Taizhou 31
Bari 29
Redondo Beach 29
San Francisco 28
Chennai 27
Norwalk 27
Lanzhou 26
Redwood City 25
Da Nang 23
London 23
Napoli 23
Taiyuan 23
Padova 21
Rio de Janeiro 21
Warsaw 21
Genoa 20
Jakarta 20
Riyadh 20
Turku 20
Belo Horizonte 19
Catania 19
Fuzhou 19
Toronto 19
Abuja 18
Amsterdam 18
Montreal 18
Genova 17
Phoenix 17
Brasília 16
Brescia 16
Brooklyn 16
Fairfield 16
Lancaster 16
Torino 16
Haiphong 15
Monza 15
Seoul 15
Augusta 14
Bergamo 14
Cagliari 14
Curitiba 14
Totale 16.936
Salva come PNG Salva come JPEG
Nome #
Infezione da Klebsiella pneumoniae carbapenemasi produttrice: dati preliminari di dosaggio di tigeciclina, meropenem e colistina in plasma di pazienti ricoverati in terapia intensiva mediante cromatografia liquida ad alte prestazioni accoppiata a spettrometria di massa tandem 4.048
CEFTRIAXONE THERAPY, INTESTINAL BETA-LACTAMASES AND INTERACTION WITH PROBIOTICS IN CHILDREN 697
Proprietà farmacocinetiche e farmacodinamiche di antibiotici nel trattamento locale di infezioni protesiche 362
Variability in the release of antibiotics from PMMA bone cement spacers 262
Influenza del sito d’ infezione (pancreas) sulla farmacocinetica e farmacodinamica di piperacillina-tazobactam 254
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 251
Analysis of intestinal microflora of autistic children before and after probiotic treatment. 248
Effetti del calcio policarbofil nel bambino con stipsi 225
Antibiotics penetration in human necrotizing pancreatitis (NP). 219
Piperacillin-Tazobactam penetration into human pancreatic juice 218
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 214
Antibiotics and intestinal contents interaction 210
Farmacocinetica e farmacodinamica di piperacillina–tazobactam in pazienti con fistola pancreatica esterna 209
Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data 206
Health-promoting properties of new lactobacilli strains: in vivo models 204
Effect of dose on the intestinal concentrations of fluoroquinolones. Infection and Intensive care. Italian and British Perspectives 203
Different probiotics and intestinal microflora in antibiotic treated children 203
Antibiotic Release from removed temporary hip spacers 203
Safery and antibiotics concentrations in serum and urine after implantation of gentamicin-vancomycin-loaded spacers in patients with prosthetic joint infections 202
Evaluations of CYP 3A 4/5 and DNA damage in rat enterocytes and in human and rat lymphocytes by fluoroquinolones 200
Commercial probiotic products: evaluation of microbial content and nomenclature 199
Interazione itraconazolo-ciprofloxacina nel compartimento intestinale del ratto: dati preliminari 198
Diffusione ossea dell'associazione gentamicina-vancomicina da impianto in PMMA in osteomielite sperimentale 198
Fluoroquinolones effects on patients lymphocytes during prolonged treatments 197
BACTERIAL ADHESION ON ANTIBIOTIC-LOADED POLYMETHYLMETHACRYLATE BONE CEMENT 197
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation 196
Challenges and opportunities by bridging human and animal surveillance to tackle antimicrobial resistance 195
Effetti dei fluorochinoloni in linfociti di pazienti in trattamenti protratti. 193
FLUOROQUINOLONES: EFFECTS OF DOSE ON INTESTINAL PENETRATION, HEPATIC ISOFORMS AND DNA DAMAGE IN RAT. 190
Antibiotici e pancreas esocrino: interazioni. 189
FLUOROQUINOLONES: EFFECTS OF DOSE ON INTESTINAL PENETRATION, HEPATIC ISOFORM AND DNA DAMAGE IN RAT. 189
Antimicrobial activity of gentamicin and vancomycin combination in joint fluids after antibiotic-loaded cement spacer implantation in two-stage revision surgery. 188
Assessment of novel probiotic Lactobacillus casei strains strains for the production of functional dairy foods. 187
Antibiotics and their interaction with intestinal contents. 185
Bacterial faecal flora in healthy women of different ages. 185
Fluoroquinolones (FQs) effects on enterocytes and lymphocytes. 184
Continuous Infusion of Flumazenil in the Management of Benzodiazepines Detoxification 183
Rischio di nefrotossicità per terapia locale con cementi ossei antibiotati (aminoglicosidi e glicopeptidi) nelle infezioni protesiche. 181
Itraconazole-ciprofloxacin interaction on the pharmacokinetics of the intestinal compartment: preliminary results in rats 180
Bacterial adhesion on antibiotic-loaded polymethylmethacrylate bone cement 180
Effect of ceftriaxone along with probiotics administrationon intestinal ecosystem and beta-lactamase activity 179
Bacterial flora composition and faecal enzymes in pre- and postmenopausal women with breast cancer. 178
EFFETTI DI FLUOROCHINOLONI IN LINFOCITI DI PAZIENTI IN TRATTAMENTI PROTRATTI. 178
Health-promoting properties of new lactobacilli strains: in-vivo models 177
Effect of pancreatic enzymes administration on intestinal ecosystem in patients with exocrine pancreatic insufficiency. Preliminary results 177
Vancogenx-space for hip and knee: gentamicin and vancomycin levels in serum and urine from a multicenter trial 174
Effect of probiotics in the presence of antimicrobial therapy 173
A serum antimicrobial activity of cancer patients and interaction with different antibacterial drugs. 172
Prophylaxis of P. carinii pneumonia (PCP). in HIV-infected patients with trimethoprim/sulfametoxazole (TMP/SMX) or dapsone (DDS) 170
A different behaviour of antibiotics in presence of fresh intestinal content in vitro. 169
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer 165
Microflora intestinale ed enzimi fecali in donne con fibromatosi uterina e tumore al seno. 165
Alterazioni dell’ecosistema inestinale da antibiotici. problemi e prospettive 165
Dose-effect of fluoroquinolones on intestinal penetration, hepatic isoforms and DNA damage in the rat 165
Rilascio locale dell’associazione gentamicina-vancomicina da chiodo endomidollare in osteomielite sperimentale 164
Effetti sistemici ed intestinali dei fluorochinoloni 163
Changes in rat intestinal microflora following oral and parenteral administration of antimicrobial drugs 162
Intestinal ecosystem and metabolic capacity in women with breast cancer 161
Commercial probiotic products: evaluation of microbial content and nomenclature. 161
Health promoting of new Lactobacilli strains: in-vivo models. 161
Valutazione della compliance al dapsone (DDS) in pazienti in profilassi per PCP. 160
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer. 160
Attività antimicrobica del siero di pazienti cancerosi ed interazioni farmacologiche con diversi farmaci antibatterici 158
Release of gentamicin and vancomycin from preformed spacers in infected total hip arthroplasties: Measurement of concentrations and inhibitory activity in patients' drainage fluids and serum 158
Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis 157
Variability in the release of antibiotics from PMMA bone cement spacers 157
Twice-weekly dapsone for primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1 infection: comparative efficacy and pharmacokinetic data. 156
Different effect of pre-treatment with phenobarbital on transintestinal elimination of moxifloxacin and ciprofloxacin: preliminary data 155
Release of gentamicin and vancomycin alone and in combination from polymethylmethacrylate (PMMA) cement 153
Pk-pd parameters ratio of antibotics released from antibiotic-loaded spacers in drainage fluids. 151
Release of antibiotics from polymethylmethacrylate cement 149
Attività degli antibiotici nei sistemi biologici 149
Rilascio di antibiotici da spaziatori antibiotati nei fluidi di drenaggio 149
Premenstrual syndrome (PMS): effect of probiotic supplement and S-adenosyl-L-methionine (SAMe) on intestinal microflora. 148
Antibiotic release from removed temporary hip spacers 148
Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriazone 147
DRAINAGE AND SERUM LEVELS OF ANTIBIOTICS FOLLOWING TEMPORARY SPACER IMPLANTS IN TWO-STAGE REVISION SURGERY 147
Pefloxacin penetration into human necrotic pancreatic tissue. 146
Effects of itraconazole on the pharmacokinetics of ciprofloxacin and the intestinal metabolizing system (CYP450 and P-glycoprotein) 145
Metronidazole (MZ) penetration into pancreatic juice (P5) and necrotic pancreatic tissue (NPT). 144
Immunosuppression and antimicrobial drugs: effects on rats intestinal microflora. 143
Interleuchina –4 e ossido nitrico nella pancreatite cronica umana. 142
Behaviour of antibiotics during human necrotizing pancreatitis. 142
Behavior of antibiotics during human necrotizing pancreatitis. 142
Trattamento con fluorochinoloni ed effetti su linfociti di pazienti in politerapia prolungata 142
Preliminary evaluation of probiotic properties of L. casei strains 141
Combination of immunosuppressive treatment and antimicrobial drugs: effect on colonic microflora of rat. 140
Intestinal microflora composition in premenstrual syndrome (PMS) and effect of Lactobacillus-Bifidobacterium administration 137
Changes in rat intestinal microflora following oral and parenteral administration of antimicrobial drugs. 137
Effetto del trattamento con fluochinoloni su linfociti di pazienti in politerapia prolungata 137
Behaviour of ciprofloxacin intestinal pharmacokinetics after different timing of Itraconazole administration 137
Formazione in PNCAR 137
DOSE-EFFECTS OF FLUOROQUINOLONES (FQs) ON INTESTINAL PENETRATION, HEPATIC ISOFORMS AND DNA DAMAGE IN RAT. 136
Diverso effetto del pretrattamento con fenobarbital sull'eliminazione transintestinale di moxifloxacina e ciprofloxacina: dati preliminari 136
Diffusion into bone tissue of gentamicin-vancomycin combination from PMMA device in experimental osteomyelitis and in vitro bacterial adhesion to PMMA 136
Attività degli antibiotici nei sistemi biologici 135
Potential probiotics benefit in gastrointestinal disorders of different aetiology. 135
Effect of pancreatic enzymes administration on intestinal ecosystem in patients with exocrine pancreatic insufficiency. Preliminary results 135
Composition and metabolic activity of the intestinal microflora in pre- and postmenopausal women with breast cancer 135
Improvement of intestinal balance in chronic pancreatitis insufficiency (CPI) by antibiotic and probiotic administration. 133
Totale 21.806
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.790
article - articoli 33.470
book - libri 0
conference - conferenze 51.398
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.922
Totale 177.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.005 0 0 38 112 60 55 46 76 70 61 134 353
2022/20233.386 266 285 353 540 314 674 64 252 307 50 188 93
2023/20241.949 85 159 136 254 198 237 120 206 49 105 224 176
2024/20253.993 291 391 205 583 285 83 187 203 617 197 243 708
2025/20268.703 676 411 621 1.243 2.066 790 936 458 624 524 172 182
2026/2027971 700 270 1 0 0 0 0 0 0 0 0 0
Totale 30.714